EOLS

Evolus, Inc. Common Stock

11.57 USD
+0.04 (+0.35%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Evolus, Inc. Common Stock stock is down -9.4% since 30 days ago. The next earnings date is Jul 31, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 6 June’s closed higher than May. In the last 4 Unusual Options Trades, there were 3 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
24 Apr 16:50 17 May, 2024 12.50 CALL 1000 80
29 Apr 15:15 19 Jul, 2024 10.00 CALL 140 71
08 May 19:50 19 Jul, 2024 12.50 PUT 1100 36
14 May 17:10 17 May, 2024 12.50 CALL 1000 1204

About Evolus, Inc. Common Stock

Evolus, Inc. provides medical aesthetic products for physicians and their patients in the United States. Jeuveau is a proprietary 900 kilodalton purified botulinum toxin type A formulation for the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.